ArticleFrontiers in oncology2022

Case report: Olaparib as an experimental therapy in a BRCA2-mutated patient with metastatic ovarian adenocarcinoma that originated from liver cancer.

Caixia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.